This Monday and Tuesday, September 19 and 20, the second Oncobell Symposium was held in the auditorium of the Bellvitge University Hospital. Under the slogan “building bridges between science, medicine and people” the congress is a forum to discuss the latest advances in basic and clinical research with top-level cancer professionals
They have shown that intravenous iron administration improves the quality of life and prognosis in patients with heart failure and ventricular dysfunction.
During the academic year that is beginning, the Tandem will continue educational projects that have been successful in recent years, such as the production of Life & Science magazine, the European Stars Game project, the Women of Science series, or the implementation of new laboratory practices in charge of the URIB
Misinformation about the disease is one of the most stressful factors for patients. For this reason, creating quality content could help maintain emotional well-being.
The multicenter study in real life at the state level has been carried out with patients with severe asthma from a dozen hospitals and its main conclusion is that biological therapy is effective in both cases
An IDIBELL and the Bellvitge University Hospital study has detected that the age at which the first symptoms appear has progressively increased from 1970 to 2019.
The work shows that in a NOX4 low activity situation, liver cancer cells reprogram the metabolism, causing oxidative stress, which favors tumor progression.
Dapagliflozin significantly reduces the risk of cardiovascular death and hospitalizations for heart failure (HF).
It is an epigenetic test capable of detecting between 90 and 100% of cases of endometrial cancer. This new rapid and non-invasive method can be performed: on cervical cytology samples obtained in the doctor’s office, and on vaginal self-samples collected at home.
A retrospective study by IDIBELL and the Bellvitge University Hospital shows that starting physical rehabilitation of patients admitted to the UCRI with severe COVID-19 before seven days reduces hospitalization time.
